Curiox Biosystems Co., Ltd. logo

Curiox Biosystems Co., Ltd. (445680)

Market Open
11 Aug, 06:30
KRX SM KRX SM
41,850. 00
-850
-1.9906%
1.41T Market Cap
- P/E Ratio
- Div Yield
39,239 Volume
- Eps
42,700
Previous Close
Add Transaction
Day Range
40,150 42,150
Year Range
31,650 149,200
Want to track 445680 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

445680 trading today lower at ₩41,850, a decrease of -1.9906% from yesterday's close, completing a monthly decrease of -12.6305% or -₩6,050. Over the past 12 months, 445680 stock lost -64.2308%.
445680 is not paying dividends to its shareholders.
Curiox Biosystems Co., Ltd. has completed 1 stock splits, with the recent split occurring on Aug 06, 2024.
The company's stock is traded on one exchange.

445680 Chart

People also search for

Samsung Biologics Co., Ltd.
1,588,000
+1.211%
Celltrion Inc.
204,500
+1.7413%
ALTEOGEN Inc.
340,500
-2.1552%
Sk Biopharmaceuticals Co., Ltd.
90,600
+2.1421%
ABL Bio Inc.
92,300
-1.3889%

Curiox Biosystems Co., Ltd. (445680) FAQ

What is the stock price today?

The current price is ₩41,850.00.

On which exchange is it traded?

Curiox Biosystems Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 445680.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.41T.

Has Curiox Biosystems Co., Ltd. ever had a stock split?

Curiox Biosystems Co., Ltd. had 1 splits and the recent split was on Aug 06, 2024.

Curiox Biosystems Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
- CEO
KRX SM Exchange
- ISIN
South Korea Country
- Employees
- Last Dividend
6 Aug 2024 Last Split
- IPO Date
Curiox Biosystems Co., Ltd. is a pioneering biotechnology company specializing in innovative solutions for cellular analysis and research. The company's primary focus is on enhancing the efficiency and accuracy of laboratory procedures, notably through its patented DropArray technology. This unique platform reduces the need for centrifugation in sample preparation, offering a gentle and efficient way to handle cells across various research applications, including immuno-oncology and vaccine development. Curiox Biosystems' solutions cater to the pharmaceutical, biotechnology, and academic research industries, providing tools that streamline workflows and improve data reliability. By addressing critical challenges in cell analysis, Curiox plays a significant role in advancing scientific research and development. Headquartered in South Korea, the company has a growing global presence, supporting laboratories worldwide with its cutting-edge products and contributing to the acceleration of various therapeutic discoveries.

Contact Information

Address: -
Phone: -